Avid Bioservices Inc (CDMO)

[Protector]

Thress, that is pertinently not true.

Like at clinicaltrials.gov, 2 sponsored trials by PPHM through NCCN.

Furthermore, look how PPHM's updated web-site has this table:
Pipeline an how AstraZeneca is not removed and the 3rd NCCN trial has been mentioned to start end of this year.

PPHM wants to lisence/partner or Sell (whole or Part) of its PS-targeting but keep a node of people to coordinate effort done with NCCN, Memorial Sloan Kettering and others while letting the big boys run the end-stage clinical trials.

And then there is exosomes, biomarkers, betabodies, etc which can move forward WITHOUT Bavituximab.

AIMO